{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:21:30Z","timestamp":1771654890411,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":110,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.lrr.2020.100202","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T11:36:18Z","timestamp":1587641778000},"page":"100202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine\/lenalidomide and daratumumab without a decrease in myeloid clone size"],"prefix":"10.1016","volume":"13","author":[{"given":"Celine","family":"Berthon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgane","family":"Nudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen M.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Goursaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Marceau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Quesnel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2020.100202_bib0001","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood-2011-12-381426","article-title":"Second malignancies after multiple myeloma: from 1960s to 2010s","volume":"119","author":"Thomas","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2020.100202_bib0002","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1309\/AJCPOP7APGDT9JIU","article-title":"Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens","volume":"138","author":"Reddi","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.lrr.2020.100202_bib0003","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0165-4608(02)00792-6","article-title":"Multiple myeloma with monosomy 13 developed in trisomy 13 acute myelocytic leukemia: numerical chromosome abnormality during chromosomal segregation process","volume":"141","author":"Sashida","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.lrr.2020.100202_bib0004","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood-2011-05-355743","article-title":"Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)","volume":"118","author":"Mailankody","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2020.100202_bib0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/10428199909167402","article-title":"Primary myeloid leukemia presenting concomitantly with primary multiple myeloma: two cases and an update of the literature","volume":"32","author":"Anderson","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.lrr.2020.100202_bib0006","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/SMJ.0b013e3181fa5eeb","article-title":"Simultaneous acute myeloid leukemia and multiple myeloma successfully treated with allogeneic stem cell transplantation","volume":"103","author":"Kim","year":"2010","journal-title":"South Med J"},{"key":"10.1016\/j.lrr.2020.100202_bib0007","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12288-015-0628-9","article-title":"Synchronous Plasma Cell Myeloma and Acute Myeloid Leukemia in a Therapy-Naive Patient: A Rare Occurrence","volume":"32","author":"Kumar","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.lrr.2020.100202_bib0008","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00277-017-3032-8","article-title":"Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation","volume":"96","author":"Oka","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.lrr.2020.100202_bib0009","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.5858\/2003-127-1506-SPOMMA","article-title":"Simultaneous presentation of multiple myeloma and acute monocytic leukemia","volume":"127","author":"Luca","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.lrr.2020.100202_bib0010","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1186\/s12885-015-1743-6","article-title":"A case of simultaneous occurrence of acute myeloid leukemia and multiple myeloma","volume":"15","author":"Lu-Qun","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lrr.2020.100202_bib0011","first-page":"359","article-title":"[Acute myelogenous leukemia (M2) simultaneously associated with multiple myeloma with special reference to chromosome abnormality of t(6; 14) (p21.1; q32.3)]","volume":"31","author":"Yashige","year":"1990","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.lrr.2020.100202_bib0012","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1182\/blood-2018-99-114206","article-title":"DNA Methyltransferase Inhibitors Increase Expression of CD38 and Enhance Daratumumab Efficacy in Multiple Myeloma","volume":"132","author":"Choudhry","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2020.100202_bib0013","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1002\/cncr.32065","article-title":"Daratumumab in multiple myeloma","volume":"125","author":"Nooka","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.lrr.2020.100202_bib0014","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1038\/ncomms10767","article-title":"Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents","volume":"7","author":"Merlevede","year":"2016","journal-title":"Nat Commun"}],"updated-by":[{"DOI":"10.1016\/j.lrr.2022.100308","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000}}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221304892030008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221304892030008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:07:56Z","timestamp":1761959276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221304892030008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":14,"alternative-id":["S221304892030008X"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2020.100202","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine\/lenalidomide and daratumumab without a decrease in myeloid clone size","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2020.100202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100202"}}